指南与共识血栓与止血

D-二聚体检测的事实与误区:意大利血栓与止血学会(SISET)共识指导

Facts and Misfacts on D-Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis (SISET).
指南 / 共识 · Am J Hematol · 2025-09-29

意大利血栓与止血学会(SISET)任命专家组基于文献与专家意见制定D-二聚体使用指导。主要结论:D-二聚体联合验前临床概率可用于排除有症状门诊患者的静脉血栓栓塞症(VTE);可能有助于确定维生素K拮抗剂二级预防VTE的最佳疗程,但直接口服抗凝药领域需进一步研究;联合验前概率评分可在急诊安全排除急性主动脉综合征而无需进一步影像检查。

要点

  • D-二聚体联合验前临床概率可用于排除有症状门诊患者的VTE。
  • D-二聚体可能有助于确定维生素K拮抗剂二级预防VTE的最佳疗程,直接口服抗凝药领域需进一步研究。
  • D-二聚体联合验前概率评分可在急诊安全排除急性主动脉综合征,无需进一步影像检查。

核心结论

  • D-二聚体可可靠地联合验前临床概率用于排除有症状门诊患者的VTE。
  • D-二聚体可能有助于确定维生素K拮抗剂二级预防VTE的最佳疗程,但专家组认为直接口服抗凝药领域需进一步研究。
  • D-二聚体联合验前概率评分可在急诊安全排除急性主动脉综合征,无需进一步影像检查。

研究设计与样本

  • 意大利血栓与止血学会(SISET)任命专家组,基于文献和专家意见制定D-二聚体使用指导。

主要发现

  • 对健康人群筛查性开具D-二聚体处方可能促使医生启动耗时诊断程序,产生患者焦虑/痛苦,且常无法对患者管理得出有意义的结论。
  • 不明原因D-二聚体升高的偶然发现常被无意中当作VTE指标,可能导致不必要的血栓预防启动。
  • 人群研究表明D-二聚体升高与动脉血栓形成存在可变关联,但这些研究无法建立D-二聚体升高与疾病之间的直接因果关系,使D-二聚体测量难以适用于个体患者。

关键数值与推荐

  • D-二聚体可可靠地联合验前临床概率用于排除有症状门诊患者的VTE。
  • D-二聚体可能有助于确定维生素K拮抗剂二级预防VTE的最佳疗程,直接口服抗凝药领域需进一步研究。
  • D-二聚体联合验前概率评分可在急诊安全排除急性主动脉综合征,无需进一步影像检查。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

D-dimer defines degradation products derived from the proteolysis mediated by plasmin on cross-linked fibrin. The evidence-based use of D-dimer in some conditions has been consolidated. Currently, however, there is an entrenched prescription of D-dimer testing to screen otherwise healthy subjects that may induce prescribing physicians to start time-consuming diagnostic procedures that may generate patient anxiety/distress and often fail to reach meaningful conclusions for patients' management. To make things worse, the incidental finding of unexplained elevated D-dimer is often, and inadvertently, taken as an index of venous thromboembolism (VTE) that may induce unnecessary initiation of thromboprophylaxis. Finally, population studies showed that elevated D-dimer is variably associated with arterial thrombosis. However, the above studies do not allow establishing a direct causal relationship between elevated D-dimer and disease, which makes D-dimer measurement hardly applicable in individual patients. With this as background, the Italian Society on Thrombosis and Hemostasis appointed a panel to prepare a guidance on the use of D-dimer based on the literature and expert opinion. The main conclusions of the panel can be summarized as follows: (i) D-dimer can be reliably used in combination with pre-test clinical probability to exclude VTE in symptomatic outpatients. (ii) It may help establish the optimal duration of secondary VTE prevention with vitamin K antagonists, although the panel felt that this area needs further investigation when dealing with direct oral anticoagulants. (iv) The use of D-dimer in combination with the pre-test probability score can be used to safely rule out acute aortic syndromes in the emergency setting without further imaging tests.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Tripodi A, Ageno W, Barcella L, et al. Facts and Misfacts on D-Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis (SISET). Am J Hematol. 2025. PMID: 41017435. doi:10.1002/ajh.70079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。